Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Cytokinetics heart failure drug succeeds but slightly higher death rate seen -study Next Article
Heart polypill cuts cardiovascular disease risks by 21% over placebo in primary prevention trial »
« Cytokinetics heart failure drug succeeds but slightly higher death rate seen -study Next Article
Heart polypill cuts cardiovascular disease risks by 21% over placebo in primary prevention trial »
Related Articles
March 12, 2021
Zanidatamab provides ORR in HER2+ biliary tract cancer

© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy